Lexicon Pharmaceuticals reported 12.44 in PE Price to Earnings for its fiscal quarter ending in June of 2021.





Pe Change Date
Abbott 24.94 5.78 Mar/2026
Acadia Pharmaceuticals 10.08 1.53 Mar/2026
Agios Pharmaceuticals 3.56 0 Mar/2026
Akebia Therapeutics 1.63K 1.6K Dec/2025
Alnylam Pharmaceuticals 80.04 90.66 Mar/2026
AstraZeneca 29.59 2.3 Mar/2026
BioMarin Pharmaceutical 15.28 3.96 Mar/2026
Eli Lilly 40.27 0.06 Mar/2026
Esperion Therapeutics 129.79 129 Dec/2024
Halozyme Therapeutics 11.35 11.8 Mar/2026
Illumina 32.45 2.07 Mar/2026
Ironwood Pharmaceuticals 204.24 88.19 Dec/2024
J&J 24.53 0.91 Mar/2026
Lexicon Pharmaceuticals 12.44 4.73 Jun/2021
MannKind 201.15 102.55 Mar/2026
Merck 16.52 2.6 Mar/2026
Moderna 27.22 14.51 Jun/2023
Novartis 20.17 2.32 Mar/2026
PTC Therapeutics 9.98 3.25 Dec/2025
Puma Biotechnology 13.93 44.88 Jun/2024
Sarepta Therapeutics 27.27 0 Dec/2025
Thermo Fisher Scientific 27.71 3.29 Mar/2026
United Therapeutics 20.42 3.1 Mar/2026
Vanda Pharmaceuticals 16.79 7.07 Jun/2023